• Tidak ada hasil yang ditemukan

Biopharmaca BiofarmakaDivision

N/A
N/A
Protected

Academic year: 2017

Membagikan "Biopharmaca BiofarmakaDivision"

Copied!
2
0
0

Teks penuh

(1)

Kampus IPB Taman Kencana

Jln. Taman Kencana No. 3, Bogor 16128, INDONESIA

Telp +62-251-8373561 Fax +62-251-8347525, Mobile +62 81311195614 Email: bfarmaka@gmail.com

Website: http://biofarmaka.or.id; http://biofarmaka.ipb.ac.id

Institute of Research and Community Services

Bogor Agricultural University

TECHNICAL UNITS

Biopharmaca Conservation and Cultivation Station (BCCS)

Biopharmaca Conservation and Cultivation Station is a technical unit under the BRC. It was established for handling BRC endeavor in biopharmaca cultivation and conservation integratedly and sustainably. This station is located within IPB Darmaga Campus on 3.5 hectares. BCCS is a "showroom" for BRC activity in upstream field of biopharmaca research. This unit dealing with display, collection, and production of biopharmaca raw materials. Technical Manager: Prof. Dr. Ir. Munif Ghulamahdi, MS

Laboratory of Biopharmaca Research Center Laboratory (LBRC)

Laboratory of Biopharmaca Research Center is a technical unit under the BRC. It was established in line with BRC efforts in enhancing quality and added values of biopharmaca products. It has role for conducting services in biopharmaca quality analysis. Its services is offered for academicians, researchers, industries, private sectors, and public. LBRC has wide capability in biopharmaca quality analysis. It involves many analysis, such as phytochemical screening, proximate analysis, extraction, and efficacy test. BTL uses international standard analysis method and also uses modern analysis instrument (HPLC, FTIR, AAS, etc.).

Technical Manager: Rudi Heryanto, MSi

Animal Testing Laboratory (ATL)

Animal Testing Laboratory is a technical unit under the BRC. It was established come along with BRC efforts in enhancing quality and added values of biopharmaca research. It has role for conducting services in biopharmaca quality analysis. Its services is offered for academician, researcher, industry, private sector and public. The services are a). in vivo testing for anti-inflammatory, analgesic, LD50, sub-chronic toxicity, osteoporosis and aromatherapy, b). providing mice and rats, and c). renting the place for in-vivo testing. Quality Manager: Waras Nurcholis, MSi

Unit Pilot Plant & Workshop (UPPW)

Unit Pilot Plant & Workshop is a technical unit under the BRC. It was established for developing biopharmaca products & training. The product, which successfully developed, are herbal capsule, herbal candy, herbal instant beverage, etc., both for treatment and functional food. PPU in collaboration with PT. Biofarindo has been commercialized the products.

Quality Manager: Susi Indariani, STP., MSi

Unit Information & Public Relation (UIPR)

Unit Information & PR is a technical unit under the BRC. It was established as information center for BRC research & activities. This unit is to maintain goodwill and understanding between BRC and stakeholders.

Quality Manager: Dr. Farit Mochamad Afendi, MSi

CENTER ORGANIZATION

Advisory Board

1. Prof. Dr. dr. Agus Purwadianto (Ministry of Health RI) 2. Dean of Faculty of Agriculture IPB

3. Dean of Faculty of Forestry IPB

4. Prof. Dr. Ir. Dudung Darusman, MA (Faculty of Forestry IPB)

5. Prof. Dr. Suminar Setiati Achmadi (Faculty of Mathematic & Natural Science IPB) 6. Prof. Dr. Ir. Latifah K Darusman, MS (Faculty of Mathematic & Natural Science IPB) 7. Prof. Drh. Dondin Sajuthi, MST, Ph.D (Faculty of Veterinar IPB)

Director : Dr. Irmanida Batubara, MSi

Executive Secretary : Dr. Eng. Wisnu Ananta Kusuma, ST., MT. Technical Secretary : Siti Sa’diah, MSi., Apt & Susi Indariani, STP., MSi

Division

1. Division of Natural Resource Development & Cultivation Head : Prof. Dr. Ir. Sandra Arifin Aziz, MS.

2. Division of Biopharmaca Product Development Head : Prof. Dr. Dra. Ietjeu Wientarsih, Apt.,MSc

3. Division of Community Empowerment & Market Development Head : Dr. Ir. Leti Sundawati, MSc., FTrop.

4. Division of Collaboration & Networking Head : Dr. Ir. Yulin Lestari, MS.

Komisi Nasional Akreditasi Pranata Penelitian dan Pengembangan

PLM 046-INA

(2)

INTRODUCTION

Indonesia is a country belong to "megadiversity countries" along with Mexico, Columbia, Ecuador, Peru, Brazil, Zaire, Madagascar, China, India, Malaysia, and Australia which are believed to contain 70% of the world's species diversity. Indonesia also is a multiethnic society, with more than 1.000 ethnic/subethnic groups. This unique combination makes Indonesia become a country rich in ethnobotany information as well. The utilization of both assets will make a significant contribution to increase the welfare of Indonesian society. Therefore, within this context, Biopharmaca Research Center (BRC) was established. Biopharmaca is defined as plants, animals, mineral, and microbes that have potential properties as drugs, health food, functional food, and nutraceutica, for human, animals, and plants.

BRC is an organization belongs to Institute of Research and Community Services, Bogor Agricultural University (IPB). BRC has devoted its existence as a networking institution and for coordinating research on biopharmaca-related materials. The Center is working on

biopharmaca development, natural resources conservation,

proposing bioprospective policy and regulation. Furthermore, its multidisciplinary expertise have the capability in exploration, conservation, cultivation, extraction, chemical structure analysis, standardization, and efficacy studies of the natural resources.

VISION

To be a leading research center in biopharmaca areas by optimizing added value of natural resources at national and international level.

MISSION

1. To gather, to synergize, and to enhance cooperation and networking

amongst the human resources within units in IPB as well as outside IPB in venturing of the improvement of biopharmaca added values.

2. To develop the frontier science, arts, and technology on the development of patentable biopharmaca products which can support self-sustained nation

3. To improve human resource quality through education, trainings, and

community services

COMPETENCY

An integral research on biopharmaca and nutraceutical, from upstream to

downstream aspects through multidiscipline/ interdisciplinary strategies.

MANDATE OF RESEARCH DEVELOPMENT

Research on indigenous knowledge and technology which is related to the prevention, control disease, and medical treatment for human, animals, and plants

Research on policy for utilization and development indigenous natural resources which have potency for prevention, control, and treatment of diseases in human, animals, plants and for nutraceutical

Research on the development of GACP and GMP of indigenous natural resources as material for medicine and nutraceutical for human, animals and plants

Research on the development of standardization model for biopharmaca products and nutraceutical

Research on social and economic impact of the development of biopharmaca and nutraceutical.

SERVICES

Consultation for research on all aspects of biopharmaca development such as cultivation (conventional and biotechnological), extraction, efficacy assay, etc.

Analysis and isolation of bioactive compounds, chemical analysis, bioassays, pre-clinic tests

(in vitro and in vivo)

Standardization of raw material of biopharmaca for its bioactive content

Manufacturing of standardized medicinal plant extracts.

ATTAINING TARGETS

To explore and to investigate the bioprospecting of natural resources and the development of patentable biopharmaca product derived from indigenous knowledge. To acquire the intellectual property rights from biopharmaca products which are developed based on diseases priority (degenerative diseases, e.g., diabetes mellitus, uric acid disorder)

To obtain Standard Operation Procedures in cultivation and manufacturing biopharmaca products which is nationally and internationally recognized. To obtain standard manual (i.e. SNI, Indonesian National Standard ) for biopharmaca products, and also to obtain map of national biopharmaca potency.

To commercialize the BRC research results through production sharing or product licensing with small scale or large biopharmaca industries.

To formulate the biopharmaca development policy in national level through cooperation with stakeholders.

RESEARCH PRIORITY

Exploration and bioprospecting investigation of natural

resources and the development of patentable

biopharmaca product derived from indigenous

knowledge

Standardization of biopharmaca product and its materials. It involves the investigation of its chemical and biological (efficacy and safety) properties

Research on social and economic aspects in the

development of biopharmaca and conducting

community empowerment program through

demonstration plot and supervision

Referensi

Dokumen terkait

Hasil yang didapatkan dari penelitian ini yaitu banyak upaya yang dilakukan oleh Sanggar Gito Maron Surabaya itu sendiri untuk menjaga eksistensi dari Tari Lenggang

Akan tetapi pada tanggal 27 Januari 1999 Menteri Luar Negeri Ali Alatas mengumumkan keputusan dalam Sidang Kabinet Paripurna bidang Politik dan Keamanan mengenai

Laporan Mingguan Praktikum BIOLOGI UMUM OLEH: Nama : NIM : Kelompok : Unit :. Asisten Meja : Dosen

Adalah benar-benar Mahasiswa Fakultas Hukum Universitas Diponegoro Semarang yang masih berstatus aktif pada Semester Gasal Tahun Akademik 2017/2018. Surat Keterangan

bahw a dalam rangka pelaksanaan pem binaan pegaw ai yang m em pertim bangkan faktor jabatan sesuai dengan hasil analisis dan evaluasi jabatan, m aka perlu ditetapkan kelas jabatan

perusahaan untuk menerbitkan saham baru. Untuk memperbaiki hubungan antara perusahaan dengan konsumen, sehubungan telah terjadinya suatu peristiwa yang mengakibatkan

Dengan kurang dari 5% rakyat berpendidikan tinggi, sulit bangsa kita untuk menang berkompetisi di era globalisasi yang berbasis informasi & pengetahuan; walaupun

A pabila Saudara butuh keterangan dan penjelasan lebih lanjut, dapat menghubungi Panitia Pengadaan sesuai alamat tersebut di atas paling lambat 2 hari setelah pengumuman ini